PEAK6
VRTX icon

PEAK6’s Vertex Pharmaceuticals VRTX Stock Holding History

PEAK6’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,600
Closed -$12.5M – 3360
2025
Q4 		$12.5M Sell
27,600
-15,700
-36% -$6.77M 0.02% 546
2025
Q3 		$17M Sell
43,300
-15,200
-26% -$6.35M 0.02% 480
2025
Q2 		$26M Buy
58,500
+45,200
+340% +$20.8M 0.05% 321
2025
Q1 		$6.45M Buy
13,300
+2,300
+21% +$1.07M 0.01% 774
2024
Q4 		$4.43M Buy
+11,000
New +$5.1M 0.01% 974

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

PEAK6's VRTX Position: Q1 2026 in Review

PEAK6 reduced its Vertex Pharmaceuticals (VRTX) stake by 99% in Q1 2026, selling an estimated $125K and leaving 3 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

PEAK6 first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $13.6M in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • PEAK6 held 3 shares of Vertex Pharmaceuticals worth $1.25K as of Q1 2026.
  • PEAK6 sold 269 Vertex Pharmaceuticals shares in Q1 2026, an estimated $125K.
  • Vertex Pharmaceuticals made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #2584 holding.
  • PEAK6 first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • PEAK6's Vertex Pharmaceuticals position peaked at $13.6M in Q2 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.